Clinical Trial Update: Impact of Circadian Rhythm on Immunotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the impact of circadian rhythm on immunotherapy in advanced/metastatic non-small cell lung cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Liza Villaruz, MD | Conditions: Advanced/Metastatic NSCLC | Phase 2 | Status: RECRUITING